16 July 2015
Irkutsk, July 16, 2015 – Russian pharmaceutical company NovaMedica takes an active part in the V Baikal Forum on Inflammatory Bowel Diseases (IBD), which befalls from 16 to 18 of July in Irkutsk. Participating in this event NovaMedica opens a series of scientific and practical programs for the professional community of gastroenterologists.
“NovaMedica wants to be a driver for research and practical programs in the field of gastroenterology, as they contribute to the spread of new knowledge about innovative methods of treatment among members of the professional community, because the interest to such information increases among both the doctors and the patients,” said Medical Director of NovaMedica Zachary Leykin. “New knowledge will help doctors to be at the forefront of advanced science and clinical practice, it will enable them to master modern methods of treatment, corresponding to the high requirements of safety and efficiency that will certainly affect the treatment efficiency, improving the life quality for patients and will optimize the cost of the therapy”.
A number of experts will speak at the anniversary of the Baikal forum, organized by the Scientific Center of Reconstructive and Restorative Surgery, including Professor Igor Khalif, who will give guidelines on conservative treatment of patients. PhD Elena Chashkova in the report “On the pages of history: the alliance of the endoscopist and the clinician” will tell about new possibilities of drug therapy of inflammatory bowel disease. Professor Alexander Potapov will share their experience in the field of optimization of treatment of crohn's disease in children. A booth presenting innovative products from gastroenterology portfolio of NovaMedica will run in the forum.
The diapason of events, supported by NovaMedica, is wide: from regional to international, from schools for young professionals to congresses and conferences with participation of leading doctors and scientists. In addition to participating in the V Baikal forum in Irkutsk, in August NovaMedica’s experts will speak at the IV Caspian Forum in Astrakhan (IBD) and at the IX Educational Course with international participation for doctors-gastroenterologists in Moscow. In October the specialists of our company will actively participate in the 21st Russian Gastroenterological Week, and in November – in the International Congress of specialists in inflammatory bowel diseases in Lisbon (Portugal), which will be visited by doctors from many countries, including the Russian gastroenterologists.
NovaMedica is a Russian pharmaceutical company established in 2012 by DRI Holdings Limited, a portfolio company of Domain Associates LLC, and Russian investment corporation RUSNANO, which implements government policy of fostering the development of hi-tech industries. The company’s strategy is aimed at localizing production of a wide range of new medicines and technologies in the Russian market, including screening and registration of new pharmaceuticals, and the creation of innovative GMP-standard manufacturing facilities.
For more information: www.novamedica.comPrint
30 September 2020
29 September 2020
29 September 2020
28 September 2020